JP

Jetharam Patel

Active Director Director DIN 10668065
DIN 10668065 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Jetharam Patel

Data last updated:

Jetharam Patel is a Director at Enomark Pharma Private Limited (since 2024). The company operates in Pharma. Enomark Pharma Private Limited reported revenue of ₹2.56 Cr (FY 2025).

DIN 10668065
Primary Designation Director
Industry Pharma
First Appointment 14 Jun 2024
Oldest Company Age 10 yrs
Largest company Enomark Pharma Private Limited · ₹2.56 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Enomark Pharma Private Limited U51909MH2016PTC282093
Director14 Jun 20242016₹2.56 Cr (FY 2025)Active

Board colleagues of Jetharam Patel

Directorship timeline

Open interactive timeline →
Enomark Pharma Private Limited
Premium access

Shareholding and investment profile for Jetharam Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jetharam Patel

Jetharam Patel currently holds 1 directorship: Enomark Pharma Private Limited (Director, since 14 Jun 2024, revenue ₹2.56 Cr (FY 2025)).

Jetharam Patel was first appointed on 14 Jun 2024 as Director at Enomark Pharma Private Limited.

The current boards of Jetharam Patel's companies include Laxmanram Ruparam Patel (Enomark Pharma Private Limited), Shriram Sawalram Patel (Enomark Pharma Private Limited), Umesh Ruparam Patel (Enomark Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available